Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US71742Q1067
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG000C31ZH2
PAHC
Phibro Animal Health Corp
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Drug Manufacturers - Specialty & Generic · THEMEFOLIO: $HLTH
NAME
Phibro Animal Health Corp
ISIN
US71742Q1067
TICKER
PAHC
MIC
XNAS
REUTERS
PAHC.OQ
BLOOMBERG
PAHC US
Di., 03.11.2026       Phibro Animal Health
US71742Q1067

The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December 16, 2026, to stockholders of record at the close of business on November 25, 2026. About Phibro Animal Health Corporation Phibro Animal H...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Mi., 28.10.2026       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its first quarter financial results on Wednesday, November 4, 2026, after the market closes. Phibro management will host a conference call and webcast on Thursday, November 5, 2026, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Mi., 09.09.2026       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Morgan Stanley Annual Global Healthcare Conference. President & Chief Executive Officer, Daniel Bendheim; Chief Operating Officer, Larry Miller; and Chief Financial Officer, Glenn David will address financial analysts and investors on Tuesday, Septembe...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Di., 01.09.2026       Phibro Animal Health
US71742Q1067

Das Instrument PB8 US71742Q1067 PHIBRO ANIMAL HEALTH A EQUITY wird ex Dividende/Zinsen gehandelt am 02.09.2026 The instrument PB8 US71742Q1067 PHIBRO ANIMAL HEALTH A EQUITY has its ex-dividend/interest day on 02.09.2026...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Mi., 26.08.2026       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its fourth quarter and fiscal year ended June 30, 2026 and provided its financial guidance for the fiscal year ending June 30, 2027. Highlights for the three months ended June 30, 2026 (compared to the three months ended June 30, 202...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Mi., 19.08.2026       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its fourth quarter and fiscal year 2026 financial results on Wednesday, August 26, 2026, after the market closes. Phibro management will host a conference call and webcast on Thursday, August 27, 2026, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conf...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Di., 28.07.2026       Phibro Animal Health
US71742Q1067

The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, , payable on September 23, 2026, to stockholders of record at the close of business on September 2, 2026.About Phibro Animal Health CorporationPhibro Animal Healt...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Do., 21.05.2026       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Stifel Jaws & Paws Conference. Executive Vice President, Corporate Strategy & CEO Designate, Daniel Bendheim; Chief Operating Officer, Larry Miller; and Chief Financial Officer, Glenn David will address financial analysts and investors on Wednesday...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Do., 07.05.2026       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Bank of America Securities Health Care Conference. Executive Vice President, Corporate Strategy & CEO Designate Daniel Bendheim; Chief Operating Officer, Larry Miller and Chief Financial Officer, Glenn David will address financial analysts and investor...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Mi., 06.05.2026       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its third quarter ended March 31, 2026, and its updated financial guidance for the year ending June 30, 2026. Highlights for the three months ended March 31, 2026 (compared to the three months ended March 31, 2025): Net sales of $...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Di., 05.05.2026       Phibro Animal Health
US71742Q1067

The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 24, 2026, to stockholders of record at the close of business on June 3, 2026. About Phibro Animal Health Corporation Phibro Animal Health Corpor...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Di., 05.05.2026       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the launch of its new Sustainable Solutions Platform (SSP), a companywide initiative designed to help animal protein, dairy and petfood producers address greenhouse gas emissions through practical, science-based solutions that integrate seamlessly into existing feed and production sys...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Mi., 29.04.2026       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its third quarter financial results on Wednesday, May 6, 2026, after the market closes. Phibro management will host a conference call and webcast on Thursday, May 7, 2026, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the prese...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Mo., 27.04.2026       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) today announced expected implementation of a new regulatory framework governing the use of certain antimicrobials in Brazil that have growth promotion indications. The Brazilian Ministry of Agriculture and Livestock (MAPA) published Ordinance No. 1617 on April 27, 2026, prohibiting the importation,...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Mi., 18.02.2026       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Bank of America 2026 Virtual Animal Health Summit. Chief Financial Officer, Glenn David; Chief Operating Officer, Larry Miller and Executive Vice President, Corporate Strategy and CEO designate Daniel Bendheim will address financial analysts and investors...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Mi., 04.02.2026       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its second quarter ended December 31, 2025, and its updated financial guidance for the year ending June 30, 2026. Highlights for the three months ended December 31, 2025 (compared to the three months ended December 31, 2024): Net...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Di., 03.02.2026       Phibro Animal Health
US71742Q1067

The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on March 25, 2026, to stockholders of record at the close of business on March 4, 2026. About Phibro Animal Health Corporation Phibro Animal Health Cor...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Mi., 28.01.2026       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its second quarter financial results on Wednesday, February 4, 2026, after the market closes. Phibro management will host a conference call and webcast on Thursday, February 5, 2026, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and vie...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Do., 18.12.2025       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) (the “Company” or “Phibro”) today announced a leadership transition that will support the Company’s continued growth and long-term strategic direction. At the end of this fiscal year, effective July 1, 2026, Jack Bendheim, current Chairman, Chief Executive Officer and President of Phibro will take on...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Mo., 24.11.2025       Phibro Animal Health
US71742Q1067

Das Instrument PB8 US71742Q1067 PHIBRO ANIMAL HEALTH A EQUITY wird cum Dividende/Zinsen gehandelt am 25.11.2025 und ex Dividende/Zinsen am 26.11.2025 The instrument PB8 US71742Q1067 PHIBRO ANIMAL HEALTH A EQUITY has its pre-dividend/interest day on 25.11.2025 and its ex-dividend/interest day on 26.11.2025...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Mi., 05.11.2025       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its first quarter ended September 30, 2025 and its updated financial guidance for the year ending June 30, 2026. Highlights for the three months ended September 30, 2025 (compared to the three months ended September 30, 2024) Net sa...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Di., 04.11.2025       Phibro Animal Health
US71742Q1067

The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December 17, 2025, to stockholders of record at the close of business on November 26, 2025. About Phibro Animal Health Corporation Phibro Animal Heal...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Do., 30.10.2025       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation is proud to announce the national launch of Restoris™ piezoelectric dental gel, a revolutionary dental gel designed to treat and support long-term oral health in dogs with periodontal disease. Developed in collaboration with a leading U.S. dental school and licensed to Phibro, Restoris represents a breakthrough in...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Mi., 29.10.2025       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its first quarter financial results on Wednesday, November 5, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, November 6, 2025, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Do., 09.10.2025       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC), a global leader in animal health and nutrition, today announced it has entered into a licensing agreement with Lighthouse Pharmaceuticals, Inc. for a novel therapeutic asset targeting periodontal health in companion animals. This agreement grants Phibro exclusive rights to develop, manufacture, an...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Di., 02.09.2025       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Morgan Stanley Annual Global Healthcare Conference. Chief Financial Officer, Glenn David will address financial analysts and investors on Tuesday, September 9, 2025, at 12:20 PM ET at the Sheraton New York Times Square Hotel. The live audio presentation...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Mi., 27.08.2025       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its fourth quarter and fiscal year ended June 30, 2025 and provided its financial guidance for the year ending June 30, 2026. Highlights for the three months ended June 30, 2025 (compared to the three months ended June 30, 2024) N...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Mi., 20.08.2025       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its fourth quarter and fiscal year 2025 financial results on Wednesday, August 27, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, August 28, 2025, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conf...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Di., 29.07.2025       Phibro Animal Health
US71742Q1067

The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on September 24, 2025, to stockholders of record at the close of business on September 3, 2025. About Phibro Animal Health Corporation Phibro Animal He...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Do., 22.05.2025       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Stifel Jaws & Paws Conference. Chief Operating Officer, Larry Miller along with Director and Executive Vice President, Corporate Strategy, Daniel Bendheim will address financial analysts and investors on Thursday, May 29, 2025, at 8:35 AM ET at the Lott...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Mi., 07.05.2025       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its third quarter ended March 31, 2025, and its updated financial guidance for the year ending June 30, 2025. Highlights for the three months ended March 31, 2025 (compared to the three months ended March 31, 2024) Net sales of $347...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Di., 06.05.2025       Phibro Animal Health
US71742Q1067

The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 25, 2025, to stockholders of record at the close of business on June 4, 2025. About Phibro Animal Health Corporation Phibro Animal Health Corpo...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Mi., 23.04.2025       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its third quarter financial results on Wednesday, May 7, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, May 8, 2025, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presen...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Mi., 05.03.2025       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Barclays Annual Global Healthcare Conference. Chief Financial Officer, Glenn David will address financial analysts and investors on Thursday, March 13, 2025, at 9:00 AM ET at the Loews Miami Beach Hotel. The live audio presentation will be available on the...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Di., 04.03.2025       Phibro Animal Health
US71742Q1067

Das Instrument PB8 US71742Q1067 PHIBRO ANIMAL HEALTH A EQUITY wird ex Dividende/Zinsen gehandelt am 05.03.2025 The instrument PB8 US71742Q1067 PHIBRO ANIMAL HEALTH A EQUITY has its ex-dividend/interest day on 05.03.2025...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Mo., 03.03.2025       Phibro Animal Health
US71742Q1067

Das Instrument PB8 US71742Q1067 PHIBRO ANIMAL HEALTH A EQUITY wird cum Dividende/Zinsen gehandelt am 04.03.2025 und ex Dividende/Zinsen am 05.03.2025 The instrument PB8 US71742Q1067 PHIBRO ANIMAL HEALTH A EQUITY has its pre-dividend/interest day on 04.03.2025 and its ex-dividend/interest day on 05.03.2025...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Do., 20.02.2025       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Bank of America 2025 Virtual Animal Health Summit. Chief Financial Officer, Glenn David will address financial analysts and investors on Thursday, February 27, 2025, at 10:50 AM ET. The live audio presentation will be available on the Phibro Animal Health...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Mi., 05.02.2025       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its second quarter ended December 31, 2024, and its updated financial guidance for the year ending June 30, 2025. Highlights for the three months ended December 31, 2024 (compared to the three months ended December 31, 2023) Net s...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Di., 04.02.2025       Phibro Animal Health
US71742Q1067

The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on March 26, 2025, to stockholders of record at the close of business on March 5, 2025. About Phibro Animal Health Corporation Phibro Animal Health C...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Do., 23.01.2025       Phibro Animal Health
US71742Q1067

The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the appointment of Joyce J. Lee, MBA, as a Class II director of the Company, effective immediately. Ms. Lee will be an independent director. Her appointment fills a current vacancy and increases Board membership to nine directors, 6 of whom are independent di...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Mi., 22.01.2025       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its second quarter financial results on Wednesday, February 5, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, February 6, 2025, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and vie...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Mo., 25.11.2024       Phibro Animal Health
US71742Q1067

Das Instrument PB8 US71742Q1067 PHIBRO ANIMAL HEALTH A EQUITY wird cum Dividende/Zinsen gehandelt am 26.11.2024 und ex Dividende/Zinsen am 27.11.2024 The instrument PB8 US71742Q1067 PHIBRO ANIMAL HEALTH A EQUITY has its pre-dividend/interest day on 26.11.2024 and its ex-dividend/interest day on 27.11.2024...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Mi., 06.11.2024       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its first quarter ended September 30, 2024, and its updated financial guidance for the year ending June 30, 2025. Highlights for the three months ended September 30, 2024 (compared to the three months ended September 30, 2023) Net s...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Di., 05.11.2024       Phibro Animal Health
US71742Q1067

The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December 18, 2024, to stockholders of record at the close of business on November 27, 2024. About Phibro Animal Health Corporation Phibro Animal Hea...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Do., 31.10.2024       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the successful completion of the acquisition of the medicated feed additive product portfolio and certain water-soluble products from Zoetis Inc. (NYSE:ZTS). This acquisition marks a significant step in furthering Phibro’s purpose to optimize global animal health and nutrition for bet...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Mi., 23.10.2024       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its first quarter financial results on Wednesday, November 6, 2024, after the market closes. Phibro management will host a conference call and webcast on Thursday, November 7, 2024, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Di., 03.09.2024       Phibro Animal Health
US71742Q1067

Das Instrument PB8 US71742Q1067 PHIBRO ANIMAL HEALTH A EQUITY wird ex Dividende/Zinsen gehandelt am 04.09.2024 The instrument PB8 US71742Q1067 PHIBRO ANIMAL HEALTH A EQUITY has its ex-dividend/interest day on 04.09.2024...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Do., 29.08.2024       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Morgan Stanley Annual Global Healthcare Conference. Chief Financial Officer, Glenn David along with Chief Operating Officer, Larry Miller will address financial analysts and investors on Thursday, September 5, 2024, at 1:05 PM ET at the New York Marriott M...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Mi., 28.08.2024       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its fourth quarter and fiscal year ended June 30, 2024 and provided its financial guidance for the year ending June 30, 2025. Highlights for the three months ended June 30, 2024 (compared to the three months ended June 30, 2023) N...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink
Mi., 14.08.2024       Phibro Animal Health
US71742Q1067

Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its fourth quarter and fiscal year 2024 financial results on Wednesday, August 28, 2024, after the market closes. Phibro management will host a conference call and webcast on Thursday, August 29, 2024, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conf...
Zur Nachricht
Phibro Animal Health
Charts & Research Termsheets Terminal
Permalink